Literature DB >> 24291341

Estimating the decline in excess risk of cerebrovascular disease following quitting smoking--a systematic review based on the negative exponential model.

Peter N Lee1, John S Fry2, Alison J Thornton3.   

Abstract

We attempted to quantify the decline in stroke risk following quitting using the negative exponential model, with methodology previously employed for IHD. We identified 22 blocks of RRs (from 13 studies) comparing current smokers, former smokers (by time quit) and never smokers. Corresponding pseudo-numbers of cases and controls/at risk formed the data for model-fitting. We tried to estimate the half-life (H, time since quit when the excess risk becomes half that for a continuing smoker) for each block. The method failed to converge or produced very variable estimates of H in nine blocks with a current smoker RR <1.40. Rejecting these, and combining blocks by amount smoked in one study where problems arose in model-fitting, the final analyses used 11 blocks. Goodness-of-fit was adequate for each block, the combined estimate of H being 4.78(95%CI 2.17-10.50) years. However, considerable heterogeneity existed, unexplained by any factor studied, with the random-effects estimate 3.08(1.32-7.16). Sensitivity analyses allowing for reverse causation or differing assumed times for the final quitting period gave similar results. The estimates of H are similar for stroke and IHD, and the individual estimates similarly heterogeneous. Fitting the model is harder for stroke, due to its weaker association with smoking.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CI; DF; H; IARC; IHD; International Agency for Research on Cancer; Negative exponential model; Quitting smoking; REF; RR; SE; Stroke; confidence interval; degrees of freedom; half-life; ischaemic heart disease; relative risk; standard error; unique reference code for study

Mesh:

Year:  2013        PMID: 24291341     DOI: 10.1016/j.yrtph.2013.11.013

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

Review 1.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  Circulation       Date:  2016-11-04       Impact factor: 29.690

2.  Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia.

Authors:  Jae Jeong Yang; Danxia Yu; Xiao-Ou Shu; Wanqing Wen; Shafiur Rahman; Sarah Abe; Eiko Saito; Prakash C Gupta; Jiang He; Shoichiro Tsugane; Yu-Tang Gao; Jian-Min Yuan; Woon-Puay Koh; Atsuko Sadakane; Yasutake Tomata; Ichiro Tsuji; Yumi Sugawara; Keitaro Matsuo; Yoon-Ok Ahn; Sue K Park; Yu Chen; Manami Inoue; Daehee Kang; Wei Zheng
Journal:  Int J Epidemiol       Date:  2021-02-05       Impact factor: 7.196

3.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  J Am Coll Cardiol       Date:  2016-11-04       Impact factor: 24.094

Review 4.  Appropriate and inappropriate methods for investigating the "gateway" hypothesis, with a review of the evidence linking prior snus use to later cigarette smoking.

Authors:  Peter N Lee
Journal:  Harm Reduct J       Date:  2015-03-20

5.  Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up.

Authors:  Niloofar Taghizadeh; Judith M Vonk; H Marike Boezen
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

6.  Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2).

Authors:  Frank Lüdicke; Patrick Picavet; Gizelle Baker; Christelle Haziza; Valerie Poux; Nicola Lama; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2018-01-05       Impact factor: 4.244

Review 7.  Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B2.

Authors:  Angela van der Plas; Sandrine Pouly; Guillaume de La Bourdonnaye; Wee Teck Ng; Gizelle Baker; Frank Lüdicke
Journal:  Toxicol Rep       Date:  2018-04-19

8.  The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review.

Authors:  Peter N Lee; Barbara A Forey; Alison J Thornton; Katharine J Coombs
Journal:  F1000Res       Date:  2018-02-19

Review 9.  Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.

Authors:  Peter N Lee; David Abrams; Annette Bachand; Gizelle Baker; Ryan Black; Oscar Camacho; Geoffrey Curtin; Smilja Djurdjevic; Andrew Hill; David Mendez; Raheema S Muhammad-Kah; Jose Luis Murillo; Raymond Niaura; Yezdi B Pithawalla; Bill Poland; Sandra Sulsky; Lai Wei; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

10.  Estimating the reduction in US mortality if cigarettes were largely replaced by e-cigarettes.

Authors:  Peter N Lee; John S Fry; Stanley Gilliland; Preston Campbell; Andrew R Joyce
Journal:  Arch Toxicol       Date:  2021-10-22       Impact factor: 5.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.